Gilead Sciences, Inc. (NASDAQ:GILD) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Gilead Sciences, Inc.

Dorothy L. Holbrook, age 91, of Galion passed away Sunday August 10, 2025 at Trustwell Living in Mansfield. Born January 5, 1934 in Ivyton, KY, she was the daughter of the late Will and Molly ...

U.S. stocks are drifting near their record heights as Wall Street waits for an upcoming update on inflation.

• Mount Gilead at Upper Sandusky, girls’ golf, 1:30 p.m. • Mount Gilead, Fredericktown and Harding at Cardington, boys’ golf, 4:30 p.m. • Northmor at Margaretta, girls’ golf, 5 p.m. • Highland at ...

Kymera Therapeutics' Q2 2025 earnings call highlights clinical progress, Gilead and Sanofi partnerships, and financial strength, setting a strong stage ...

Instead of confronting the structural forces that create and sustain homelessness, these strategies shift responsibility onto ...

The global HIV antivirals market is set for a period of robust growth, with a new forecast predicting its value will climb from an estimated USD 34.8 billion in 2025 to USD 53.6 billion by 2035. This ...

Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...

Deutsche Bank analyst James Shin raised the firm’s price target on Gilead (GILD) to $135 from $120 and keeps a Buy rating on the shares. Published ...

A wave of factory closures is reshaping regional economies, displacing skilled laborers and weakening supply chains.